Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis-Reference-Cited by-同舟云学术

Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis

Published:2022-04-25 Issue:7 Volume:47 Page:1324-1336
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Experimental Derm

Author:

Soenen Rani¹²^ORCID,Wang Zhigang²^ORCID,Grine Lynda¹^ORCID,Dreesen Erwin²^ORCID,Schots Lisa¹^ORCID,Brouwers Els²^ORCID,Declerck Paul²^ORCID,Thomas Debby²^ORCID,Lambert Jo¹^ORCID

Affiliation:

1. Department of Dermatology Ghent University Hospital Ghent Belgium

2. Department of Pharmaceutical and Pharmacological Sciences KU Leuven Leuven Belgium

Funder

Fonds Wetenschappelijk Onderzoek

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.15157

Reference51 articles.

1. Cause‐specific mortality in patients with psoriasis and psoriatic arthritis

2. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity

3. PASI90 response: the new standard in therapeutic efficacy for psoriasis

4. Treatment goals for psoriasis: Should PASI 90 become the standard of care?

5. No need to change the drug class: ixekizumab- following secukinumab-therapy in psoriasis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ixekizumab trough concentrations in psoriasis: Paving the way towards personalised therapy: A cohort study;JEADV Clinical Practice;2024-07-04

2. Exposure–response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis;Journal of the European Academy of Dermatology and Venereology;2024-05-08

3. Blocking interleukin‐17 in psoriasis: Real‐world experience from the PsoPlus cohort;Journal of the European Academy of Dermatology and Venereology;2023-01-13

4. Weighing in on weight‐based secukinumab dosing for psoriasis;British Journal of Dermatology;2022-05-16